| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1390507A2 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 02/25/2004 | EP1390371A1 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
| 02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/25/2004 | EP1200443B1 Aromatic esters of camptothecins and methods to treat cancers |
| 02/25/2004 | EP1087934B1 Aminocyclohexyl ether compounds and uses thereof |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1139592C Camptothecin derivatives its preparing and use and midbody |
| 02/24/2004 | US6696574 Processes and intermediates for preparing glycogen phosphorylase inhibitors |
| 02/24/2004 | US6696476 Pyranoindazoles and their use for the treatment of glaucoma |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes |
| 02/24/2004 | US6696461 Tricyclic imidazopyridines |
| 02/24/2004 | US6696459 Using high affinity, high selectivity quinoline derivativesw |
| 02/24/2004 | US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom |
| 02/24/2004 | US6696455 Nitrogen compounds such as 6-chloro-2-methyl-4-oxo-pyrido (3,2-d)pyrimidine used as anticarcinogenic agents and/or for prophylaxis of infections caused by pneumocystis or toxoplasma |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696439 Heterocyclic imines such as 2-methyl-3-(2-(n',n'-diethylamino) ethyl)-5-(4-propanesulfonylbenzamide)furo(3,2-b)pyridine, hydrochloride, used as serotonin receptor antagonists for prophylaxis of headaches |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/19/2004 | WO2004015119A2 Methods for the isolation and purification of ansamitocins |
| 02/19/2004 | WO2004014918A1 Nitro and amino substituted topoisomerase agents |
| 02/19/2004 | WO2004014917A2 Antitumoral analogs of lamellarins |
| 02/19/2004 | WO2004014916A1 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014906A2 Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents |
| 02/19/2004 | WO2004014901A1 Process for preparing zolmitriptan compounds |
| 02/19/2004 | WO2004014899A1 Thiophene compounds |
| 02/19/2004 | WO2004014877A1 Process for preparing rizatriptan |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014424A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 02/19/2004 | WO2004014361A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/19/2004 | WO2004014150A1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 02/19/2004 | WO2003101995A3 Camptothecins with a modified lactone ring |
| 02/19/2004 | WO2003089423A3 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 02/19/2004 | WO2003086306A3 5ht2c receptor modulators |
| 02/19/2004 | WO2003080623A8 Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof |
| 02/19/2004 | WO2003027234A9 Small organic molecule regulators of cell proliferation |
| 02/19/2004 | US20040034076 Such as methyl-3-azido-2-((4,6-dimethoxy-2-pyrimidinyl)oxy) 3,3-diphenylpropionate; for treatment of high blood pressure |
| 02/19/2004 | US20040034052 Antitumor agents |
| 02/19/2004 | US20040034050 Homo-camptothecin derivatives |
| 02/19/2004 | US20040034049 A benzofuran derivatives for treating neurodegenerative disease, such as Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis and Huntington's disease |
| 02/19/2004 | US20040034033 Novel anticancer conjugates of camptothecin and unsaturated fatty acids |
| 02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
| 02/19/2004 | US20040034005 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 02/19/2004 | US20040033993 Treatment of cardiovascular and related pathologies |
| 02/19/2004 | US20040033992 Treatment of cardiovascular and related pathologies |
| 02/19/2004 | US20040033991 Treating of cardiovascular and related pathologies |
| 02/19/2004 | US20040033990 Administering mixtures of heterocyclic imines, calcium channel blockers, adrenergic blocking agents, anticoagulants, diuretics and angiotensin converting enzyme inhibitors, for prophylaxis of heart diseases such as arrhythmias or necrosis |
| 02/19/2004 | US20040033989 Treatment of cardiovascular and related pathologies |
| 02/19/2004 | CA2493908A1 Thiophene compounds |
| 02/19/2004 | CA2493725A1 Antitumoral analogs of lamellarins |
| 02/18/2004 | EP1389616A1 Novel benzylpiperidine compound |
| 02/18/2004 | EP1389611A1 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/18/2004 | EP1389210A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same |
| 02/18/2004 | EP1196410B1 Respiratory syncytial virus replication inhibitors |
| 02/18/2004 | EP0759922B1 New antagonist compounds |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476435A Fluorinated quinolones as antimitotic and antitumor agents |
| 02/17/2004 | US6693202 Multibinding ligands containing such as amine, amide, ester, hydroxyl, carbamate, urea and/or imino functionality |
| 02/17/2004 | US6693197 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino- [2,3-f] quinoline |
| 02/17/2004 | US6693092 Herbicides; pesticides |
| 02/17/2004 | US6692950 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
| 02/17/2004 | CA2302965C Processes and intermediates for preparing anti-cancer compounds |
| 02/12/2004 | WO2004013282A2 Bis (amino acid) molecular scaffolds |
| 02/12/2004 | WO2004013146A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 02/12/2004 | WO2004013141A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | WO2004013120A1 Novel benzodioxoles |
| 02/12/2004 | WO2004012671A2 Substituted furo [2,3-b] pyridine derivatives |
| 02/12/2004 | WO2004012661A2 Novel anticancer conjugates of camptothecin and unsaturated fatty acids |
| 02/12/2004 | WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments |
| 02/12/2004 | WO2003090672A3 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/12/2004 | WO2003053561A3 A surfactant assisted nanomaterial generation process |
| 02/12/2004 | WO2003020700A3 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 02/12/2004 | US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 02/12/2004 | US20040030078 Novel photochromic polymers and methods of synthesizing same |
| 02/12/2004 | US20040029947 R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease |
| 02/12/2004 | US20040029946 Topical applying |
| 02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 02/12/2004 | US20040029915 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 02/12/2004 | US20040029914 Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 02/12/2004 | US20040029908 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 02/12/2004 | US20040029904 Spiro(2H-1benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029861 Using compound containing pyridine ring |
| 02/12/2004 | US20040029835 Antitumor agents |
| 02/12/2004 | DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/11/2004 | EP1387850A2 Antiviral nucleosides |
| 02/11/2004 | EP1387845A2 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE |
| 02/11/2004 | EP1387842A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387612A1 Pyridinyl fused bicyclic amide as fungicides |
| 02/11/2004 | EP1020462B1 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 02/11/2004 | CN1474821A New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 02/11/2004 | CN1473832A Synthesis method of [3aS, 6aR]-1,3-dibenzyl-tetrahydro-4H-fruo [3,4-d]-imidazolyl-2,4 [1H]-diketone [I] |
| 02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 02/11/2004 | CN1137894C Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |